Treatment with a dual amylin and calcitonin receptor agonist improves metabolic health in an old, obese, and ovariectomized rat model

OBJECTIVES: Menopause is often characterized by detrimental metabolic changes, such as obesity, insulin resistance, and impaired glucose tolerance, often requiring treatment. KeyBioscience Peptides (KBPs) are Dual Amylin and Calcitonin Receptor Agonists which have shown promising metabolic effects i...

Descripción completa

Detalles Bibliográficos
Autores principales: Katri, Anna, Reker, Ditte, Karsdal, Morten A., Bay-Jensen, Anne-Christine, Henriksen, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284344/
https://www.ncbi.nlm.nih.gov/pubmed/33399320
http://dx.doi.org/10.1097/GME.0000000000001722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284344/
https://www.ncbi.nlm.nih.gov/pubmed/33399320
http://dx.doi.org/10.1097/GME.0000000000001722

Ejemplares similares